Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes
暂无分享,去创建一个
J. Lancaster | A. Gutin | J. Garber | M. Robson | A. Kurian | S. Domchek | J. Lanchbury | J. Weitzel | S. Wagner | B. Roa | E. Rosenthal | Elisha Hughes | Shannon Gallagher | Placede Tshiaba | Placede T Tshiaba | S. Gallagher | P. Tshiaba
[1] J. Lancaster,et al. Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk , 2020, JCO precision oncology.
[2] S. Astley,et al. A case–control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density , 2019, International journal of cancer.
[3] M. García-Closas,et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors , 2019, Genetics in Medicine.
[4] Kristen S Purrington,et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes , 2018, American Journal of Human Genetics.
[5] C. Turnbull,et al. Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group , 2018, Journal of Medical Genetics.
[6] S. Astley,et al. Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction , 2018, JAMA oncology.
[7] C. Vachon,et al. Common Genetic Variation and Breast Cancer Risk—Past, Present, and Future , 2018, Cancer Epidemiology, Biomarkers & Prevention.
[8] Gary D Bader,et al. Association analysis identifies 65 new breast cancer risk loci , 2017, Nature.
[9] Michael Jones,et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer , 2017, Nature Genetics.
[10] Alexander Gutin,et al. Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women. , 2017, JCO precision oncology.
[11] W. Chung,et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers , 2017, JAMA.
[12] Jack Cuzick,et al. Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] A. Whittemore,et al. Genetic modifiers of CHEK2*1100delC associated breast cancer risk , 2016, Genetics in Medicine.
[14] Michael Jones,et al. Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] H. LaDuca,et al. Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers. , 2016, Cancer genetics.
[16] Mark E. Robson,et al. Counselling framework for moderate-penetrance cancer-susceptibility mutations , 2016, Nature Reviews Clinical Oncology.
[17] Jacques Simard,et al. Incorporating Truncating Variants in PALB2, CHEK2 and ATM into the BOADICEA Breast Cancer Risk Model , 2016, Genetics in Medicine.
[18] A. Antoniou,et al. Refining Breast Cancer Risk Stratification: Additional Genes, Additional Information. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[19] G. Giles,et al. Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[20] Nazneen Rahman,et al. Gene-panel sequencing and the prediction of breast-cancer risk. , 2015, The New England journal of medicine.
[21] Satish Bhatnagar,et al. T E C H N I C a L a D V a N C E Open Access , 2022 .
[22] Jane E. Carpenter,et al. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants , 2015, JNCI Journal of the National Cancer Institute.
[23] Patrick Neven,et al. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer , 2015 .
[24] D. Pruss,et al. Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes , 2014, Breast Cancer Research and Treatment.
[25] K. Nathanson,et al. Common breast cancer risk variants in the post-COGS era: a comprehensive review , 2013, Breast Cancer Research.
[26] Diana Eccles,et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. , 2013, Journal of the National Cancer Institute.
[27] W. Chung,et al. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk , 2013, PLoS genetics.
[28] D. Altshuler,et al. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk , 2013, PLoS genetics.
[29] Päivi Heikkilä,et al. Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[30] W. Foulkes,et al. Inherited Mutations in Breast Cancer Genes—Risk and Response , 2011, Journal of Mammary Gland Biology and Neoplasia.
[31] Mads Thomassen,et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. , 2010, Cancer research.
[32] Montserrat Garcia-Closas,et al. Genetic susceptibility to breast cancer , 2010, Molecular oncology.
[33] Dieter Niederacher,et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2008, American journal of human genetics.
[34] S. Bojesen,et al. CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] M. Yaffe,et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.
[36] S. Seal,et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene , 2007, Nature Genetics.
[37] L. Esserman,et al. Genetic/familial high-risk assessment , 2010 .
[38] Nazneen Rahman,et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles , 2006, Nature Genetics.
[39] O. Kallioniemi,et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. , 2002, American journal of human genetics.
[40] Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases , 2000 .